Evaluation of the sST2-guided optimization of medical treatments of patients admitted for heart failure, to prevent readmission: Study protocol for a randomized controlled trial

Contemp Clin Trials. 2018 Mar:66:45-50. doi: 10.1016/j.cct.2018.01.007. Epub 2018 Feb 4.
No abstract available

Publication types

  • Clinical Trial Protocol

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Aminobutyrates / therapeutic use
  • Angiotensin Receptor Antagonists / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Biphenyl Compounds
  • Cardiovascular Agents / therapeutic use
  • Drug Combinations
  • Female
  • Heart Failure / blood
  • Heart Failure / drug therapy*
  • Humans
  • Interleukin-1 Receptor-Like 1 Protein / blood*
  • Ivabradine / therapeutic use
  • Male
  • Mineralocorticoid Receptor Antagonists / therapeutic use
  • Patient Care Planning
  • Patient Readmission*
  • Randomized Controlled Trials as Topic
  • Sodium Potassium Chloride Symporter Inhibitors / therapeutic use
  • Tetrazoles / therapeutic use
  • Valsartan

Substances

  • Adrenergic beta-Antagonists
  • Aminobutyrates
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Biphenyl Compounds
  • Cardiovascular Agents
  • Drug Combinations
  • IL1RL1 protein, human
  • Interleukin-1 Receptor-Like 1 Protein
  • Mineralocorticoid Receptor Antagonists
  • Sodium Potassium Chloride Symporter Inhibitors
  • Tetrazoles
  • Ivabradine
  • Valsartan
  • sacubitril and valsartan sodium hydrate drug combination